Wells Fargo’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$85 | – | 7130 |
|
|
2024
Q1 | $85 | Hold |
1
| – | – | ﹤0.01% | 6701 |
|
|
2023
Q4 | $107 | Hold |
1
| – | – | ﹤0.01% | 6752 |
|
|
2023
Q3 | $140 | Hold |
1
| – | – | ﹤0.01% | 6673 |
|
|
2023
Q2 | $284 | Hold |
1
| – | – | ﹤0.01% | 6603 |
|
|
2023
Q1 | $410 | Hold |
1
| – | – | ﹤0.01% | 6604 |
|
|
2022
Q4 | $156 | Hold |
1
| – | – | ﹤0.01% | 6694 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6922 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | +$833 | ﹤0.01% | 7069 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6801 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7016 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6710 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6668 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6721 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6687 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6545 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6496 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6436 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6515 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6515 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6466 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6213 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6490 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6470 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6418 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6260 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6250 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6150 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6046 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 5847 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 5857 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5910 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5894 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5907 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5874 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5782 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5632 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5592 |
|
Other funds holding HEPA
AC
XT
TRCT
Wells Fargo's HEPA Position: Q2 2024 in Review
Wells Fargo sold out of Hepion Pharmaceuticals (HEPA) in Q2 2024, closing a stake of 1 share — an estimated $85 sold.
Wells Fargo first reported a position in HEPA in Q2 2022 and held it in 8 quarters. The position peaked at $410 in Q1 2023. 18 funds tracked by Wall St. Rank hold HEPA as of Q2 2024.
- Wells Fargo reported no remaining Hepion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 1 Hepion Pharmaceuticals share in Q2 2024, an estimated $85.
- Wells Fargo first reported a position in Hepion Pharmaceuticals in Q2 2022 and held it in 8 quarters.
- Wells Fargo's Hepion Pharmaceuticals position peaked at $410 in Q1 2023.
- 18 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.